Dr. Mariotti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Moffitt Cancer Center
12902 USF Magnolia Dr
Tampa, FL 33612
Education & Training
Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 2015 - 2018
University of Florence Faculty of MedicineClass of 2006
Certifications & Licensure
VA State Medical License 2021 - 2026
NJ State Medical License 2016 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsA Gene Panel Associated With Abemaciclib Utility in-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression.Jamie O Brett, Taronish D Dubash, Gabriela N Johnson, Andrzej Niemierko, Veronica Mariotti
JCO Precision Oncology. 2023-05-01 - Increased expression of musashi 1 on breast cancer cells has implication to understand dormancy and survival in bone marrow.George R Nahas, Lauren S Sherman, Garima Sinha, Markos H El Far, Andrew Petryna
Aging. 2023-03-29 - 6 citationsEmerging immunotherapeutic strategies for the treatment of breast cancer.Laura A. Huppert, Veronica Mariotti, A. Jo Chien, Hatem Soliman
Breast Cancer Research and Treatment. 2021-10-30
Lectures
- Efficacy of abemaciclib (abema) after palbociclib (palbo) in patients (pts) with metastatic breast cancer (MBC).2019 ASCO Annual Meeting - 6/1/2019
- ARID1a as a marker of prognosis and increased sensitivity to CDK4/6, mTOR 1/2 and Src homology region 2 phosphatase (SHP 1/2) inhibitors in breast cancer (BC).2019 ASCO Annual Meeting - 6/1/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
